Atlas Trials

Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy

Clinical trial NCT03390738 · WITHDRAWN

Trial details

NCT number
NCT03390738
Sponsor
The University of Hong Kong
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2018-06-01
Primary completion
2019-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.